Filters: Author is Higano, Celestia S [Clear All Filters]
Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2014.
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy.. The New England journal of medicine.. 2014.
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates.. Anti-cancer drugs. 28(1):120-126.. 2017.
PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3520-6.. 2011.
Targeting the androgen receptor signaling axis to reduce testosterone levels in prostate cancer: how low should we go? Oncology (Williston Park, N.Y.). 28(8):700-1.. 2014.
Quantitative and stoichiometric analysis of the microRNA content of exosomes.. Proceedings of the National Academy of Sciences of the United States of America. 111(41):14888-93.. 2014.
Androgen deprivation for prostate cancer.. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. 2013:176-83.. 2013.
Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer.. The Canadian journal of urology. 22(6):8048-55.. 2015.
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.. The Journal of urology. 194(6):1537-47.. 2015.
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014.
HUMORAL IMMUNE RESPONSE AGAINST NON-TARGETED TUMOR ANTIGENS AFTER TREATMENT WITH SIPULEUCEL-T AND ITS ASSOCIATION WITH IMPROVED CLINICAL OUTCOME.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2015.
Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.. Clinical & experimental metastasis.. 2015.
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016.
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.. Nature communications. 7:13668.. 2016.
Potential use of custirsen to treat prostate cancer.. OncoTargets and therapy. 6:785-97.. 2013.
Intermittent versus continuous androgen deprivation therapy.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(5):727-33.. 2014.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)